Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price dropped 0.4% on Friday. The stock traded as low as $0.85 and last traded at $0.85. 991 shares were traded during mid-day trading, a decline of 89% from the average session volume of 9,053 shares. The stock had previously closed at $0.8535.
Peak Pharmaceuticals Trading Down 0.4%
The stock’s 50-day simple moving average is $0.95 and its 200-day simple moving average is $1.28.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Further Reading
- Five stocks we like better than Peak Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
